Globestar Therapeutics Corp (GSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Sales | 28 | 22 | 32 | 17 | 3 |
| Total expenses | 175 | 127 | 192 | 346 | 125 |
| Operating Income | -147 | -105 | -160 | -329 | -122 |
| Interest Expense | 356 | 67 | 196 | 108 | 56 |
| Pre-tax Income | -503 | -172 | -356 | -437 | -178 |
| Net Income Continuous | -503 | -172 | -356 | -437 | -178 |
| Net Income | $-503 | $-172 | $-356 | $-437 | $-178 |
| EPS Basic Continuous Ops | -2.88 | -0.01 | -0.03 | -0.05 | -0.02 |
| EPS Basic Total Ops | -2.88 | -0.01 | -0.03 | -0.05 | -0.02 |
| EPS Diluted Continuous Ops | -2.88 | -0.01 | -0.03 | -0.05 | -0.02 |
| EPS Diluted Total Ops | -2.88 | -0.01 | -0.03 | -0.05 | -0.02 |
| EBITDA(a) | $200 | $-39 | $33 | $-192 | $-81 |